PAI PARTNERS
PAI PARTNERS is a Series C+ and buyout fund in the US and Europe writing $200M–$700M checks into Healthcare, food-consumer, business-services and industrial-goods-services.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, food-consumer, business-services, industrial-goods-services
- Check size
- $200M–$700M
- Invests in
- US-wide, Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 1872
- Assets under management
- €33B
- Website
- paipartners.com
Thesis
PAI Partners is a prominent French private equity firm established in 1872, focusing on direct buyout investments in European mid and large-cap companies. They target companies with enterprise values between €300 million and €3 billion, deploying equity tickets of €200 million to €700 million. Their strategy centers on operational transformation and value creation within the 'real economy,' with a strong emphasis on four core sectors: Food & Consumer, Business Services, Healthcare, and Industrial Goods & Services. While primarily European, they also selectively invest in North America. As of December 2024, they manage approximately €33 billion in AUM, with flagship funds like PAI Partners VIII securing €7.1 billion. They do not invest in growth equity, venture capital, real estate, or private debt.
Common questions
Does PAI PARTNERS invest at the Series C+ stage?
Yes. PAI PARTNERS lists Series C+ and buyout among the stages it invests in.
What check size does PAI PARTNERS write?
PAI PARTNERS writes $200M–$700M checks.
Where does PAI PARTNERS invest?
PAI PARTNERS invests in the US and Europe.